Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tatiana Segura
Duke University, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tempo Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Segura has an equity stake in Tempo Therapeutics and rights to intellectual property that her former institution, UCLA, licensed to the company. The results of the research could be beneficial to Tempo Therapeutics’ intellectual property portfolio and commercial interests.
Engineering Injectable Microporous Hydrogels for Brain Repair
Project Narrative Stroke is the leading cause of adult disability in the United States. However, there are no current treatments. We propose that plastic-like materials can be engineered to unlock the regenerative capacity of the brain and promote functional recovery. This proposal investigates the structure/function relationship of a plastic-like material, engineered to be compatible within the brain, to promote brain repair and functional recovery. �
Filed on February 01, 2019.
Tell us what you know about Tatiana Segura's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Tatiana Segura filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | $0 - $4,999 |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | Value cannot be readily determined |
| Tatiana Segura | Duke University | Conflict of Interest | Tempo Therapeutics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.